Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale

NANot yet recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

December 31, 2026

Conditions
Coronary Microvascular DysfunctionResistant HypertensionHypertensive Heart Disease
Interventions
DIAGNOSTIC_TEST

Invasive Physiological Assessment of Coronary Circulation

After 2 months long rule-in phase required to exclude the unsuitable patients, study population will undergo RDN as indicated to treat resistant or difficult to control hypertension; 12 months after RDN, they will undergo invasive physiological study, comprehensive of Coronary Flow Reserve, Index of Microvascular Resistance, Mean Transit Time. These data will be then compared to the baseline ones obtained during the screening phase.

All Listed Sponsors
lead

Aurelia Hospital

OTHER

NCT05994729 - Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale | Biotech Hunter | Biotech Hunter